Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (244)
  3. Review (13)
  4. Guidelines (10)
  5. Research Letter (9)
  6. Book Section (6)
  7. Editorial (4)
  8. Correspondence (3)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (664)
  2. Department of Medicine (664)
  3. Hematologic Malignancies, Division of (664)
  4. Lymphoma (664)
  5. Population Sciences Research Program (664)
  6. Survivorship Research (170)

More Groups

People
  1. Alison Moskowitz (231)
  2. Andrew Zelenetz (166)
  3. Paul Hamlin (137)
  4. Ariela Noy (136)
  5. David Straus (121)
  6. Maria Palomba (109)

More People

Years
  1. 2025 (12)
  2. 2024 (50)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Annals of Oncology (18)
  5. Blood Advances (18)
  6. Leukemia and Lymphoma (18)

More Publications

Publishers
  1. American Society of Hematology (276)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (33)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (22)

More Publishers

Results (664)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Koch, R.; Porcu, P.; Oki, Y.; Moskowitz, A.; Perez, M.; Myskowski, P.; Officer, A.; Jaffe, J. D.; Morrow, S. N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
    Journal Article

    Flinn, I. W.; O’Brien, S.; Kahl, B.; Patel, M.; Oki, Y.; Foss, F. F.; Porcu, P.; Jones, J.; Burger, J. A.; Jain, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet?
    Journal Article

    Geller, S.; Myskowski, P. L.; Kim, Y. H.; Moskowitz, A.; Horwitz, S.
    British Journal of Dermatology (2018)

    Fulltext@MSK | Save
  • T-cell lymphomas, version 2.2018: Featured updates to the NCCN Guidelines
    Journal Article

    Horwitz, S. M.; Ansell, S. M.; Ai, W. Z.; Barnes, J.; Barta, S. K.; Choi, M.; Clemens, M. W.; Dogan, A.; Greer, J. P.; Halwani, A.; more...
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2016 American Society of Hematology Annual Meeting and Exposition: Commentary
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2017)

    Fulltext@MSK | Save
  • Measurement of PD-1 expression on lymphoma cells by flow cytometry is a useful tool in diagnosing and monitoring minimal residual disease in angioimmunoblastic T-cell lymphoma
    Meeting Abstract

    Yabe, M.; Ozkaya, N.; Gao, Q.; Pichardo, J.; Huet, S.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with anaplastic large cell lymphoma, anaplastic lymphoma kinase-positive (ALCL, ALK+): Data from 119 patients prospectively registered in the International T-Cell Project
    Meeting Abstract

    Shustov, A.; Bellei, M.; Pileri, S. A.; Montoto, S.; Manni, M.; Horwitz, S. M.; Cabrera, M. E.; Chiattone, C.; Nagler, A.; de Villambrosia, S. G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative (ALCL, ALK-): Analysis of 203 patients prospectively registered in the International T-Cell Project
    Meeting Abstract

    Shustov, A.; Cabrera, M. E.; Bellei, M.; Ko, Y. H.; Manni, M.; Horwitz, S. M.; De Souza, C. A.; Radford, J. A.; Varela, S. B.; Prates, M. V.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • The role of upfront hematopoietic stem cell transplantation (HSCT) in peripheral T-cell lymphoma (PTCL) patients in complete remission (CR) with a special focus on nodal PTCL: Report from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a prospective multicenter cohort study
    Meeting Abstract

    Park, S. I.; Horwitz, S. M.; Foss, F. M.; Pinter-Brown, L. C.; Carson, K. R.; Rosen, S. T.; Pro, B.; Hsi, E. D.; Federico, M.; Gisselbrecht, C.; more...
    Blood (2017)

    Fulltext@MSK | Save